This Article Full Text Full Text (PDF) All Versions of this Article: 1940-6207.CAPR-08-0146v1 2/3/251    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Okino, S. T. Articles by Dahiya, R. Search for Related Content PubMed PubMed Citation Articles by Okino, S. T. Articles by Dahiya, R. Related Collections Oncogenesis Oncogenesis: In Vitro

Toxic and Chemopreventive Ligands Preferentially Activate Distinct Aryl Hydrocarbon Receptor Pathways: Implications for Cancer Prevention

Authors' Affiliation: Department of Urology, San Francisco Veterans Affairs Medical Center and the University of California at San Francisco, San Francisco, California

Requests for reprints: Rajvir Dahiya, Department of Urology, San Francisco Veterans Affairs Medical Center and University of California at San Francisco, 4150 Clement Street (112F), San Francisco, CA 94121. Phone: 415-750-6964; Fax: 415-750-6639; E-mail: Rdahiya{at}urology.ucsf.edu.

The aryl hydrocarbon receptor (AhR) is a ligand-activated regulatory protein that controls estrogen action through two distinct pathways. In one pathway, AhR acts as a transcription factor that induces the expression of the CYP1 family of estrogen-metabolizing genes; in the other pathway, AhR initiates the degradation of the estrogen receptor and suppresses estrogen signaling. The AhR ligand 3,3'-diindolylmethane (DIM) is a beneficial dietary constituent that prevents breast tumors in rodents and is associated with decreased breast cancer risk in humans. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a toxic AhR ligand that is implicated in birth defects, infertility, and cancer. We analyzed MCF-7 cells to gain insight into how two AhR ligands can exert such fundamentally different health effects. We find that DIM and TCDD have differing abilities to activate the distinct AhR-controlled pathways. TCDD strongly induces AhR-dependent CYP1 gene expression, whereas DIM is a relatively weak CYP1 inducer. DIM strongly inhibits estrogen receptor- expression and estrogen signaling, whereas TCDD has a notably weaker effect on these processes. Small interfering RNA knockdown of AhR confirms that the effects of DIM and TCDD are indeed AhR dependent. Our findings reveal that DIM and TCDD each elicit a unique pattern of change in pathways that control estrogen action; such patterns may determine if an AhR ligand has beneficial or adverse health effects.

Key Words: aryl hydrocarbon receptor • 3,3'-diindolylmethane • 2,3,7,8-tetrachlorodibenzo-p-dioxin • breast cancer • chemoprevention